The 3rd annual World Biosimilar Congress in Geneva is where the who’s who of the global drug development industry meets to establish key strategic partnerships and shape industry best practice to optimise biosimilar drug development, demonstrate clinical success and ensure commerciality of the market. If you’re planning to attend one dedicated Biosimilar drug event make the right choice and maximise your time at the largest commercial gathering for biosimilar and biobetter drug developers. Join leading biosimilar drug executives, European regulators, SME biotechs and a selection of industry leading solution providers to gain insight and foresight into the next 18 months of this massively growing industry.